These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18940459)

  • 1. Amyloid-beta vaccination for Alzheimer's dementia.
    Holtzman JL
    Lancet; 2008 Oct; 372(9647):1381; author reply 1381-2. PubMed ID: 18940459
    [No Abstract]   [Full Text] [Related]  

  • 2. Amyloid-beta vaccination for Alzheimer's dementia.
    McGeer PL
    Lancet; 2008 Oct; 372(9647):1381; author reply 1381-2. PubMed ID: 18940458
    [No Abstract]   [Full Text] [Related]  

  • 3. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine approach for Alzheimer's disease revisited.
    Frantz S
    Nat Rev Drug Discov; 2004 Sep; 3(9):726-7. PubMed ID: 15368652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in developing anti-Alzheimer drugs].
    Tabira T
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):34P-36P. PubMed ID: 12491773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of amyloid-based therapies for Alzheimer's disease.
    Tariot PN
    CNS Spectr; 2007 Jan; 12(1 Suppl 1):7-10. PubMed ID: 17712915
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's disease: is a vaccine possible?
    Alves RP; Yang MJ; Batista MT; Ferreira LC
    Braz J Med Biol Res; 2014 Jun; 47(6):438-44. PubMed ID: 24878604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical observations with AN-1792 using TAPIR analyses.
    Hock C; Nitsch RM
    Neurodegener Dis; 2005; 2(5):273-6. PubMed ID: 16909009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Amyloid formation as a potential therapeutic target for Alzheimer's disease.
    Cordell B
    Annu Rev Pharmacol Toxicol; 1994; 34():69-89. PubMed ID: 8042857
    [No Abstract]   [Full Text] [Related]  

  • 10. Can we prevent Alzheimer's disease?
    Almeida OP
    Braz J Psychiatry; 2005 Dec; 27(4):264-5. PubMed ID: 16358105
    [No Abstract]   [Full Text] [Related]  

  • 11. Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer's disease.
    Vitti A; Piazzolla G; Condelli V; Nuzzaci M; Lanorte MT; Boscia D; De Stradis A; Antonaci S; Piazzolla P; Tortorella C
    J Virol Methods; 2010 Nov; 169(2):332-40. PubMed ID: 20691733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccination against Alzheimer's disease?].
    Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(1):63. PubMed ID: 18081047
    [No Abstract]   [Full Text] [Related]  

  • 13. [Towards a vaccine against Alzheimer's?].
    Dodel R
    Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S18-20. PubMed ID: 24242033
    [No Abstract]   [Full Text] [Related]  

  • 14. Developing novel immunogens for an effective, safe Alzheimer's disease vaccine.
    Maier M; Seabrook TJ; Lemere CA
    Neurodegener Dis; 2005; 2(5):267-72. PubMed ID: 16909008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 16. Breaking up (amyloid) is hard to do.
    Gandy S; Heppner FL
    PLoS Med; 2005 Dec; 2(12):e417. PubMed ID: 16363913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.
    Zetterberg H; Hammarström P
    J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine trial in Alzheimer's disease is halted.
    Marder K
    Curr Neurol Neurosci Rep; 2003 Sep; 3(5):371-2. PubMed ID: 12914678
    [No Abstract]   [Full Text] [Related]  

  • 20. Crucial role of heparan sulfate proteoglycan (agrin) in beta-amyloid formation in Alzheimer's disease.
    Reilly CE
    J Neurol; 2000 Aug; 247(8):663-4. PubMed ID: 11041342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.